Aandelen in “Biotechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Abionyx Pharma |
29/11 | 1,350 EUR
0,00% |
0,00% |
|
Abivax |
2/12 | 7,850 EUR
-1,26% |
-1,26% |
Acadia Pharmaceuticals Inc |
2/12 | 16,610 USD
+1,78% |
+1,78% |
|
Accelerate Diagnostics Inc |
2/12 | 1,650 USD
-0,60% |
-0,60% |
|
Achieve Life Sciences Inc. |
2/12 | 4,380 USD
-0,68% |
-0,68% |
|
Actelis Networks Inc |
2/12 | 1,270 USD
+3,25% |
+3,25% |
|
Actinium Pharmaceuticals Inc |
2/12 | 1,410 USD
-2,08% |
-2,08% |
|
Adaptimmune Therapeutics Plc |
2/12 | 0,723 USD
+0,35% |
+0,35% |
Addex Therapeutics Ltd |
2/12 | 0,058 CHF
-6,13% |
-6,13% |
|
Addex Therapeutics Ltd |
2/12 | 8,360 USD
-4,02% |
-4,02% |
|
Adicet Bio Inc |
2/12 | 1,120 USD
-0,88% |
-0,88% |
|
Aditx Therapeutics Inc |
2/12 | 0,370 USD
0,00% |
0,00% |
|
Adma Biologics Inc |
2/12 | 19,690 USD
-2,09% |
-2,09% |
|
Adocia |
29/11 | 7,500 EUR
0,00% |
0,00% |
|
Advaxis, Inc. |
2/12 | 0,080 USD
+196,30% |
+196,30% |
|
Adverum Biotechnologies Inc |
2/12 | 6,880 USD
+3,61% |
+3,61% |
|
Affimed N.V. |
2/12 | 2,780 USD
-2,11% |
-2,11% |
|
Agenus Inc |
2/12 | 3,730 USD
+9,06% |
+9,06% |
|
Agilent Technologies Inc. |
2/12 | 139,580 USD
+1,17% |
+1,17% |
|
Agios Pharmaceuticals Inc |
2/12 | 58,870 USD
-0,88% |
-0,88% |
|
AIM ImmunoTech Inc |
2/12 | 0,217 USD
-5,69% |
-5,69% |
|
Akebia Therapeutics Inc. |
2/12 | 2,130 USD
+3,40% |
+3,40% |
|
Alaunos Therapeutics Inc
|
2/12 | 2,576 USD
-0,16% |
-0,16% |
|
Aldeyra Therapeutics Inc |
2/12 | 4,820 USD
-1,63% |
-1,63% |
|
Alector Inc |
2/12 | 2,510 USD
-3,09% |
-3,09% |
|
Alkermes plc |
2/12 | 29,370 USD
+1,21% |
+1,21% |
|
Allogene Therapeutics Inc |
2/12 | 2,550 USD
+2,82% |
+2,82% |
|
AlloVir Inc |
2/12 | 0,531 USD
-3,03% |
-3,03% |
|
Alnylam Pharmaceuticals Inc |
2/12 | 253,010 USD
-0,02% |
-0,02% |
|
Alterity Therapeutics Ltd |
2/12 | 1,520 USD
+7,80% |
+7,80% |
|
Amgen |
2/12 | 278,100 USD
-1,69% |
-1,69% |
|
Amicus Therapeutics Inc |
2/12 | 9,960 USD
-0,20% |
-0,20% |
|
Amoeba |
2/12 | 0,740 EUR
-5,13% |
-5,13% |
|
AnaptysBio Inc |
2/12 | 24,380 USD
-2,32% |
-2,32% |
|
Anavex Life Sciences Corporation |
2/12 | 9,320 USD
-1,48% |
-1,48% |
|
Anixa Biosciences Inc |
2/12 | 3,140 USD
-4,85% |
-4,85% |
|
Applied Therapeutics Inc |
2/12 | 1,750 USD
-13,79% |
-13,79% |
|
Aprea Therapeutics Inc |
2/12 | 3,120 USD
+7,59% |
+7,59% |
|
Aptevo Therapeutics Inc |
2/12 | 0,237 USD
-15,24% |
-15,24% |
|
Aptose Biosciences Inc |
2/12 | 0,184 USD
+1,04% |
+1,04% |
|
AquaBounty Technologies Inc |
2/12 | 0,900 USD
-9,09% |
-9,09% |
|
Arbutus Biopharma Corp |
2/12 | 3,460 USD
0,00% |
0,00% |
|
Arcus Biosciences Inc |
2/12 | 15,940 USD
+3,24% |
+3,24% |
|
Ardelyx Inc |
2/12 | 5,540 USD
-2,29% |
-2,29% |
|
Armata Pharmaceuticals Inc |
2/12 | 2,200 USD
-4,35% |
-4,35% |
|
Array Technologies Inc |
2/12 | 6,680 USD
-0,45% |
-0,45% |
|
Arrowhead Pharmaceuticals Inc. |
2/12 | 26,340 USD
+1,19% |
+1,19% |
|
Arvinas Inc |
2/12 | 25,720 USD
-3,74% |
-3,74% |
|
Ascendis Pharma A/S |
2/12 | 133,510 USD
-1,89% |
-1,89% |
|
Aspira Women's Health Inc |
2/12 | 0,860 USD
-3,38% |
-3,38% |
|
Atara Biotherapeutics Inc |
2/12 | 13,140 USD
+7,93% |
+7,93% |
|
Athira Pharma Inc |
2/12 | 0,645 USD
-1,56% |
-1,56% |
|
Aurinia Pharmaceuticals Inc |
2/12 | 9,100 USD
+2,71% |
+2,71% |
|
Autolus Therapeutics plc |
2/12 | 3,260 USD
-1,81% |
-1,81% |
Avacta Group Plc |
2/12 | 47,000 GBX
-2,49% |
-2,49% |
|
Avalon GloboCare Corp |
2/12 | 2,450 USD
-12,50% |
-12,50% |
Avicanna Inc |
2/12 | 0,335 CAD
-5,63% |
-5,63% |
|
Avid Bioservices Inc |
2/12 | 12,320 USD
+0,33% |
+0,33% |
|
Avidity Biosciences Inc |
2/12 | 41,300 USD
-4,02% |
-4,02% |
|
AvidXchange Holdings Inc |
2/12 | 11,370 USD
-0,61% |
-0,61% |
|
AVITA Medical Inc |
2/12 | 13,000 USD
+1,40% |
+1,40% |
|
Axon Enterprise Inc |
2/12 | 636,390 USD
-1,63% |
-1,63% |